Lipid homeostasis, lipotoxicity and the metabolic syndrome

Ford, 2002, Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey, JAMA, 287, 356, 10.1001/jama.287.3.356 Reaven, 1988, Banting lecture 1988. Role of insulin resistance in human disease, Diabetes, 37, 1595, 10.2337/diabetes.37.12.1595 Ford, 2005, Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S, Diabetes Care, 28, 2745, 10.2337/diacare.28.11.2745 H.F.a.B. Wells, Jean C., Dietary assessment of major trends in U.S. food consumption, 1970–2005, in: USDA (Ed.), Economic Information Bulletin No. (E1B-33), 2008, p. 27. Lanningham-Foster, 2003, Labor saved, calories lost: the energetic impact of domestic labor-saving devices, Obes. Res., 11, 1178, 10.1038/oby.2003.162 Pelleymounter, 1995, Effects of the obese gene product on body weight regulation in ob/ob mice, Science, 269, 540, 10.1126/science.7624776 Shimabukuro, 1997, Direct antidiabetic effect of leptin through triglyceride depletion of tissues, Proc. Natl. Acad. Sci. U. S. A., 94, 4637, 10.1073/pnas.94.9.4637 Zhou, 1997, Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation, Proc. Natl. Acad. Sci. U. S. A., 94, 6386, 10.1073/pnas.94.12.6386 Szczepaniak, 2005, Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population, Am. J. Physiol., 288, E462 Oral, 2002, Leptin-replacement therapy for lipodystrophy, N. Engl. J. Med., 346, 570, 10.1056/NEJMoa012437 Shimomura, 1999, Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy, Nature, 401, 73, 10.1038/43448 Scherer, 1995, A novel serum protein similar to C1q, produced exclusively in adipocytes, J. Biol. Chem., 270, 26746, 10.1074/jbc.270.45.26746 Zhang, 1994, Positional cloning of the mouse obese gene and its human homologue, Nature, 372, 425, 10.1038/372425a0 Elmquist, 2001, Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin, Physiol. Behav., 74, 703, 10.1016/S0031-9384(01)00613-8 Unger, 2001, Diseases of liporegulation: new perspective on obesity and related disorders, FASEB J., 15, 312, 10.1096/fj.00-0590 McGavock, 2006, Adiposity of the heart, revisited, Ann. Intern. Med., 144, 517, 10.7326/0003-4819-144-7-200604040-00011 Poitout, 2002, Minireview: secondary beta-cell failure in type 2 diabetes—a convergence of glucotoxicity and lipotoxicity, Endocrinology, 143, 339, 10.1210/en.143.2.339 Chiu, 2001, A novel mouse model of lipotoxic cardiomyopathy, J. Clin. Invest., 107, 813, 10.1172/JCI10947 Pillutla, 2005, Perfusion of hearts with triglyceride-rich particles reproduces the metabolic abnormalities in lipotoxic cardiomyopathy, Am. J. Physiol. Endocrinol. Metab., 288, E1229, 10.1152/ajpendo.00273.2004 Lee, 2007, Metabolic mechanisms of failure of intraportally transplanted pancreatic beta-cells in rats: role of lipotoxicity and prevention by leptin, Diabetes, 56, 2295, 10.2337/db07-0460 Cruz, 2001, Glucose and insulin stimulate heparin-releasable lipoprotein lipase activity in mouse islets and INS-1 cells. A potential link between insulin resistance and beta-cell dysfunction, J. Biol. Chem., 276, 12162, 10.1074/jbc.M010707200 Chen, 1996, Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy, Proc. Natl. Acad. Sci. U. S. A., 93, 14795, 10.1073/pnas.93.25.14795 Orci, 2004, Rapid transformation of white adipocytes into fat-oxidizing machines, Proc. Natl. Acad. Sci. U. S. A., 101, 2058, 10.1073/pnas.0308258100 McGarry, 1977, A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis, J. Clin. Invest., 60, 265, 10.1172/JCI108764 Lee, 2006, Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy, J. Clin. Endocrinol. Metab., 91, 2605, 10.1210/jc.2005-1545 Lee, 2006, Alpha-lipoic acid prevents lipotoxic cardiomyopathy in acyl CoA-synthase transgenic mice, Biochem. Biophys. Res. Commun., 344, 446, 10.1016/j.bbrc.2006.03.062 Crandall, 2008, The prevention of type 2 diabetes, Nat. Clin. Pract. Endocrinol. Metab., 4, 382, 10.1038/ncpendmet0843 Smith, 2007, Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia, Am. J. Physiol. Endocrinol. Metab., 293, E172, 10.1152/ajpendo.00677.2006 Yu, 2004, Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition, Diabetologia, 47, 2012, 10.1007/s00125-004-1570-9 Higa, 1999, Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats, Proc. Natl. Acad. Sci. U. S. A., 96, 11513, 10.1073/pnas.96.20.11513 Sreenan, 1996, Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone, Am. J. Physiol., 271, E742 Zhou, 2000, Lipotoxic heart disease in obese rats: implications for human obesity, Proc. Natl. Acad. Sci. U. S. A., 97, 1784, 10.1073/pnas.97.4.1784 Nawrocki, 2006, Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists, J. Biol. Chem., 281, 2654, 10.1074/jbc.M505311200 Kiraly, 2007, Attenuation of type 2 diabetes mellitus in the male Zucker diabetic fatty rat: the effects of stress and non-volitional exercise, Metabolism, 56, 732, 10.1016/j.metabol.2006.12.022 Pold, 2005, Long-term AICAR administration and exercise prevents diabetes in ZDF rats, Diabetes, 54, 928, 10.2337/diabetes.54.4.928 Ruderman, 1981, The “metabolically-obese,” normal-weight individual, Am. J. Clin. Nutr., 34, 1617, 10.1093/ajcn/34.8.1617 Winder, 1996, Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise, Am. J. Physiol., 270, E299 Ohneda, 1995, Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell GLUT 2 and glucose incompetence, Diabetologia, 38, 173, 10.1007/BF00400091 Kim, 2007, Obesity-associated improvements in metabolic profile through expansion of adipose tissue, J. Clin. Invest., 117, 2621, 10.1172/JCI31021 Agarwal, 2003, Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways, Trends Endocrinol. Metab., 14, 214, 10.1016/S1043-2760(03)00078-X Addy, 2003, Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy, J. Clin. Endocrinol. Metab., 88, 627, 10.1210/jc.2002-020795 Abate, 2005, ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes, Diabetes, 54, 1207, 10.2337/diabetes.54.4.1207 Wang, 2008, Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome, Proc. Natl. Acad. Sci. U. S. A., 105, 6139, 10.1073/pnas.0801981105 Farooqi, 2007, Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor, N. Engl. J. Med., 356, 237, 10.1056/NEJMoa063988 Cullberg, 1985, Lipid metabolic studies in women with a polycystic ovary syndrome during treatment with a low-dose desogestrel-ethinylestradiol combination, Acta Obstet. Gynecol. Scand., 64, 203, 10.3109/00016348509155113 Garris, 2004, Ovarian hypercytolipidemia induced by obese (ob/ob) and diabetes (db/db) mutations: basis of female reproductive tract involution II, Tissue Cell, 36, 157, 10.1016/j.tice.2004.01.001 Murosaki, 1997, Apoptosis of intestinal intraepithelial lymphocytes induced by exogenous and endogenous glucocorticoids, Microbiol. Immunol., 41, 139, 10.1111/j.1348-0421.1997.tb01179.x Ogawa, 1992, Roles of insulin resistance and beta-cell dysfunction in dexamethasone-induced diabetes, J. Clin. Invest., 90, 497, 10.1172/JCI115886